Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Mitogen-activated protein kinase 1 | ||
Ligand | BDBM204295 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ERK2 (20 pM) Kinase Assay | ||
pH | 7.5±n/a | ||
IC50 | 0.0205±n/a nM | ||
Comments | extracted | ||
Citation | Bagdanoff, JT; Ding, Y; Han, W; Huang, Z; Jiang, Q; Jin, JX; Kou, X; Lee, P; Lindvall, M; Min, Z; Pan, Y; Pecchi, S; Pfister, KB; Poon, D; Rauniyar, V; Wang, XM; Zhang, Q; Zhou, J; Zhu, S Aminoheteroaryl benzamides as kinase inhibitors US Patent US9242996 Publication Date 1/26/2016 | ||
More Info.: | Get all data from this article, Assay Method | ||
Mitogen-activated protein kinase 1 | |||
Name: | Mitogen-activated protein kinase 1 | ||
Synonyms: | ERK2 | ERT1 | Extracellular signal-regulated kinase 2 | Extracellular signal-regulated kinase 2 (ERK-2) | Extracellular signal-regulated kinase 2 (ERK2) | MAP Kinase 2/ERK2 | MAPK 2 | MAPK1 | MK01_HUMAN | Mitogen activated kinase 1 (ERK-2) | Mitogen-activated protein kinase 1 (ERK-2) | Mitogen-activated protein kinase 1 (ERK2) | Mitogen-activated protein kinase 2 | PRKM1 | PRKM2 | p42-MAPK | ||
Type: | Ser/Thr Protein Kinase | ||
Mol. Mass.: | 41392.76 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P28482 | ||
Residue: | 360 | ||
Sequence: |
| ||
BDBM204295 | |||
n/a | |||
Name | BDBM204295 | ||
Synonyms: | US9242996, 374 | ||
Type | Small organic molecule | ||
Emp. Form. | C27H30BrF2N5O2 | ||
Mol. Mass. | 574.46 | ||
SMILES | CNC[C@@H](NC(=O)c1ccc(cc1F)-c1nc(cnc1N)[C@H]1CC[C@@H](CC1)OC)c1cc(F)cc(Br)c1 |r,wU:21.22,wD:3.3,24.29,(5.33,6.54,;4,7.31,;2.67,6.54,;2.67,5,;1.33,4.23,;,5,;,6.54,;-1.33,4.23,;-1.33,2.69,;-2.67,1.92,;-4,2.69,;-4,4.23,;-2.67,5,;-2.67,6.54,;-5.33,1.92,;-5.33,.38,;-6.67,-.39,;-8,.38,;-8,1.92,;-6.67,2.69,;-6.67,4.23,;-6.67,-1.93,;-5.33,-2.7,;-5.33,-4.24,;-6.67,-5.01,;-8,-4.24,;-8,-2.7,;-6.67,-6.54,;-5.33,-7.31,;4,4.23,;5.33,5,;6.67,4.23,;8,5,;6.67,2.69,;5.33,1.92,;5.33,.39,;4,2.69,)| | ||
Structure |